Alto Neuroscience · 14 hours ago
Accounting Clerk
Maximize your interview chances
Artificial Intelligence (AI)Biopharma
Insider Connection @Alto Neuroscience
Get 3x more responses when you reach out via email instead of LinkedIn.
Responsibilities
Prepare state payroll tax filings in coordination with our PEO
Generate and issue Form 1099s for vendors
Process and enter bills, prepare payments, reconcile accounts payable, and investigate and resolve any related issues
Assist in tracking and managing employee expense reports
Ensure accurate and timely recording of wire transfers, ACH payments, and checks
Update and maintain the company’s billing system (NetSuite) for new vendor accounts and changes to existing accounts, including product/service updates
Check and submit vendor invoices, maintain and apply customer payments in the portal, and review vendor activity to identify any missing invoices during month-end or period-end close
Assist with reconciliations, review of AP aging schedules and maintaining SOX controls on those respective areas
Process Payroll for employees
Qualification
Find out how your skills align with this job's requirements. If anything seems off, you can easily click on the tags to select or unselect skills to reflect your actual expertise.
Required
Must have 2+ years of accounts payable or accounting experience including understanding the flow of vendor payments and journal entries and knowledge of processing payroll
Experience working with a General Ledger system required; NetSuite experience is preferred
Solid critical thinking and analysis and attention to detail
Ability to maintain strict confidentiality
Team player willing to learn new tasks
Excellent written and verbal communication skills are a must
Excellent planning and organization skills, ability to handle and prioritize multiple tasks seamlessly, and work in a fast-paced, time sensitive environment
Preferred
NetSuite experience
Company
Alto Neuroscience
Alto Neuroscience is a clinical-stage biopharmaceutical company that creates precision medicines through its AI-driven biomarker platform.
Funding
Current Stage
Public CompanyTotal Funding
$239.26MKey Investors
InVivium CapitalAlpha Wave VenturesK2 HealthVentures
2024-02-02IPO· nyse:ANRO
2023-11-21Series C· $45M
2023-01-30Series B· $25M
Recent News
2024-11-04
Company data provided by crunchbase